Lindsay R. Grant
Lindsay R. Grant publishes mostly in Epidemiology, Infectious Diseases and Statistics and Probability, on topics such as Pneumonia and Respiratory Infections, Respiratory viral infections research and Influenza Virus Research Studies.
- World rank
- #208,541 of 7,710,434 ranked researchers
- Rank in United States
- #77,331 of 1,627,098
- Works
- 104
- Citations
- 2.1k
- Citations per work
- 20.3
What does Lindsay R. Grant research?
Lindsay R. Grant's work is mostly in Medicine (65%), Immunology and Microbiology (7%), Mathematics (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6764.8%
- Medicine6764.8%
- Everything else2120.3%
- Life Sciences109.9%
- Physical Sciences55.0%
- Mathematics55.0%
- 1Epidemiology58% of their works
- 2Infectious Diseases6% of their works
- 3Statistics and Probability5% of their works
- 4Molecular Biology3% of their works
- 5Immunology3% of their works
- 6Microbiology3% of their works
Research topics
- Pneumonia and Respiratory Infections
- Respiratory viral infections research
- Influenza Virus Research Studies
- Advanced Causal Inference Techniques
- Bacterial Infections and Vaccines
- Pneumocystis jirovecii pneumonia detection and treatment
- Nosocomial Infections in ICU
- Antimicrobial Resistance in Staphylococcus
Which keywords describe Lindsay R. Grant's research?
The keywords of their largest research topics: Epidemiology, Antimicrobial Resistance, Community-Acquired Pneumonia, Pneumococcal Conjugate Vaccine, Human Metapneumovirus, Respiratory Syncytial Virus, Pathogenesis and Influenza.
- Staphylococcus aureus
- ICU
- Pneumocystis
- Bacterial Meningitis
- Propensity Score
- Clinical Management
- Influenza
- Respiratory Syncytial Virus
- Pneumococcal Conjugate Vaccine
- Antimicrobial Resistance
- Epidemiology
- Community-Acquired Pneumonia
- Human Metapneumovirus
- Pathogenesis
- Virus
- Causal Inference
- Healthcare-Associated Infections
- Neisseria meningitidis
- Pneumonia
- MRSA
- Ventilator-associated Pneumonia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Epidemiology1906 topics
- Antimicrobial Resistance862 topics
- Community-Acquired Pneumonia801 topic
- Pneumococcal Conjugate Vaccine801 topic
- Human Metapneumovirus661 topic
- Respiratory Syncytial Virus661 topic
- Pathogenesis292 topics
- Influenza191 topic
- Virus191 topic
- Clinical Management162 topics
- Causal Inference141 topic
- Propensity Score141 topic
- Healthcare-Associated Infections122 topics
- Bacterial Meningitis101 topic
- Neisseria meningitidis101 topic
- Pneumocystis91 topic
- Pneumonia91 topic
- ICU61 topic
- MRSA61 topic
- Staphylococcus aureus61 topic
- Ventilator-associated Pneumonia61 topic
Where does Lindsay R. Grant work?
Lindsay R. Grant's main affiliation in the publication record is Pfizer (United States), United States.
How many publications and citations does Lindsay R. Grant have?
OpenAlex counts 104 works and 2,106 citations for Lindsay R. Grant, an h-index of 28, ranking #208,541 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lindsay R. Grant. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.